Industry News

Industry Responds to International Trade Committee s Recommendations

  • by

The Association of the British Pharmaceutical Industry (ABPI) has issued its response to the recently published report and recommendations from the International Trade Committee on the impacts of COVID-19 on international trade. In the report, the committee has found that supply chains in

Sterling Pharma Signs Agreement to Support COVID-19 Treatment Development

  • by

Contract development and manufacturing organization (CDMO), Sterling Pharma Solutions, has signed a deal with clinical stage pharmaceutical company, Moleculin Biotech, to support the development of WP1122, a potential COVID-19 treatment. According to a July 27, 2020 press release, Moleculi

EC Grants Marketing Authorization for Remsima

  • by

Celltrion Healthcare has announced in a July 27, 2020 press release, that the European Commission (EC) has granted marketing authorization for its subcutaneous (SC) formulation of Remsima (infliximab, CT-P13). Remsima SC is now approved for the treatment of adult patients with ankylosing s

FDA Maps Expectations for COVID Vaccine Proposals

With more than 100 vaccine research programs looking to address the pandemic, FDA officials are moving to clarify standards and requirements for vetting and approving viable preventives. The agency recently issued a lengthy guidance outlining recommendations for documenting vaccine quality,

GSK, Medicago Collaborate on Covid-19 Vaccine Candidate

GlaxoSmithKline (GSK) and Medicago have announced a collaboration for the development and evaluation of a COVID-19 vaccine candidate. The collaboration was revealed in a July 7, 2020 press release. The candidate vaccine will combine Medicago s recombinant coronavirus virus-like particles (